1. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Issue 10030 (30th April 2016) Authors: Fehrenbacher, Louis; Spira, Alexander; Ballinger, Marcus; Kowanetz, Marcin; Vansteenkiste, Johan; Mazieres, Julien; Park, Keunchil; Smith, David; Artal-Cortes, Angel; Lewanski, Conrad; Braiteh, Fadi; Waterkamp, Daniel; He, Pei; Zou, Wei; Chen, Daniel S; Yi, Jing; Sandler, Alan; Rittmeyer, Achim Journal: Lancet Issue: Volume 387:Issue 10030(2016) Page Start: 1837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA. (15th May 2017) Authors: Lai, Andrea Z.; Schrock, Alexa B.; Erlich, Rachel L.; Ross, Jeffrey S.; Miller, Vincent A.; Yakirevich, Evgeny; Ali, Siraj M.; Braiteh, Fadi Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA. (July 2017) Authors: Lai, Andrea Z.; Schrock, Alexa B.; Erlich, Rachel L.; Ross, Jeffrey S.; Miller, Vincent A.; Yakirevich, Evgeny; Ali, Siraj M.; Braiteh, Fadi Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4 calicheamicin antibody–drug conjugate, in patients with advanced solid tumors. Issue 7 (23rd February 2019) Authors: Garrido‐Laguna, Ignacio; Krop, Ian; Burris, Howard A.; Hamilton, Erika; Braiteh, Fadi; Weise, Amy M.; Abu‐Khalaf, Maysa; Werner, Theresa L.; Pirie‐Shepherd, Steven; Zopf, Christopher J.; Lakshminarayanan, Mani; Holland, Jaymes S.; Baffa, Raffaele; Hong, David S. Journal: International journal of cancer Issue: Volume 145:Issue 7(2019) Page Start: 1798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study. Issue 5 (8th February 2018) Authors: Gambacorti‐Passerini, Carlo; Orlov, Sergey; Zhang, Li; Braiteh, Fadi; Huang, Huiqiang; Esaki, Taito; Horibe, Keizo; Ahn, Jin‐Seok; Beck, Joseph T.; Edenfield, William Jeffrey; Shi, Yuankai; Taylor, Matthew; Tamura, Kenji; Van Tine, Brian A.; Wu, Shang‐Ju; Paolini, Jolanda; Selaru, Paulina; Kim, T... Journal: American journal of hematology Issue: Volume 93:Issue 5(2018:May) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer. (September 2019) Authors: Noor, Zorawar S.; Goldman, Jonathan W.; Lawler, William E.; Telivala, Bijoy; Braiteh, Fadi; DiCarlo, Brian A.; Kennedy, Kathleen; Adams, Brad; Wang, Xiaoyan; Jones, Benjamin; Slamon, Dennis J.; Garon, Edward B. Journal: Lung cancer Issue: Volume 135(2019) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Issue 10018 (6th February 2016) Authors: Wang-Gillam, Andrea; Li, Chung-Pin; Bodoky, György; Dean, Andrew; Shan, Yan-Shen; Jameson, Gayle; Macarulla, Teresa; Lee, Kyung-Hun; Cunningham, David; Blanc, Jean F; Hubner, Richard A; Chiu, Chang-Fang; Schwartsmann, Gilberto; Siveke, Jens T; Braiteh, Fadi; Moyo, Victor; Belanger, Bruce; Dhindsa... Journal: Lancet Issue: Volume 387:Issue 10018(2016) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies. (16th April 2015) Authors: Ali, Siraj M.; Sanford, Eric M.; Klempner, Samuel J.; Rubinson, Douglas A.; Wang, Kai; Palma, Norma A.; Chmielecki, Juliann; Yelensky, Roman; Palmer, Gary A.; Morosini, Deborah; Lipson, Doron; Catenacci, Daniel V.; Braiteh, Fadi; Erlich, Rachel; Stephens, Philip J.; Ross, Jeffrey S.; Ou, Sai-Hong... Journal: Oncologist Issue: Volume 20:Number 5(2015) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies. (16th April 2015) Authors: Ali, Siraj M.; Sanford, Eric M.; Klempner, Samuel J.; Rubinson, Douglas A.; Wang, Kai; Palma, Norma A.; Chmielecki, Juliann; Yelensky, Roman; Palmer, Gary A.; Morosini, Deborah; Lipson, Doron; Catenacci, Daniel V.; Braiteh, Fadi; Erlich, Rachel; Stephens, Philip J.; Ross, Jeffrey S.; Ou, Sai‐Hong... Journal: Oncologist Issue: Volume 20:Number 5(2015) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer. (10th October 2017) Authors: García‐Carbonero, Rocío; van Cutsem, Eric; Rivera, Fernando; Jassem, Jacek; Gore, Ira; Tebbutt, Niall; Braiteh, Fadi; Argiles, Guillem; Wainberg, Zev A.; Funke, Roel; Anderson, Maria; McCall, Bruce; Stroh, Mark; Wakshull, Eric; Hegde, Priti; Ye, Weilan; Chen, Daniel; Chang, Ilsung; Rhee, Ina; Hur... Journal: Oncologist Issue: Volume 22:Number 10(2017) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗